Reactive microgliosis participates in MPP+‐induced dopaminergic neurodegeneration: role of 67 kDa laminin receptor
- 5 April 2006
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 20 (7), 906-915
- https://doi.org/10.1096/fj.05-5053com
Abstract
It has been reported that extracellular matrix (ECM) molecules regulate monocyte activation by binding with a 67 kDa nonintegrin laminin receptor (LR). As microgliosis is a pivotal factor in propelling the progress of chronic neurodegeneration in the brain, we hypothesized that LR may regulate the microgliosis and subsequent neurotoxicity. Using 1-methyl-4-phenylpyridinium (MPP+) -treated C57 mice primary mesencephalic neuron-glia cultures as an in vitro Parkinson’s disease (PD) model, we observed that MPP+ treatment increased LR expression only in the mixed neuron-glia but not in microglia-enriched or microglia-depleted cultures, indicating that MPP+-induced increase of LR expression is associated with neuron-microglia interaction. Using confocal microscopic examination, we found that LR was localized in the microglia, which were F4/80 positive. Treatment with the antibody (Ab) against LR (LR-Ab) or YIGSR, a synthetic pentapeptide inhibitor for LR, significantly attenuated the MPP+-increased F4/80 immunoreactivity (24 h) and dopaminergic (DA) neurotoxicity. LR-Ab also attenuated MPP+-increased microglial phagocytotic activity (48 h) and the superoxide production (4 days). Further study demonstrated that exogenous laminin (1–10 μg/ml) treatment induced microglial activation and DA neurotoxicity, in a dose-dependent manner, which was partially attenuated by the LR-Ab. We concluded that by regulating cell-ECM interaction, LR plays important roles in mediating microgliosis and subsequent DA neurotoxicity. Laminin is a potential ligand for activating this LR receptor. This study also suggests that laminin/LR is a potential target for developing new therapeutic drugs against neurodegenerative disorders such as PD.—Wang, T., Zhang, W., Pei, Z., Block, M., Wilson, B., Reece, J. M., Miller, D. S., and Hong, J.-S. Reactive microgliosis participates in MPP+-induced dopaminergic neurodegeneration: role of 67 kDa laminin receptor.Keywords
This publication has 34 references indexed in Scilit:
- Cellular prion protein/laminin receptor: distribution in adult central nervous system and characterization of an isoform associated with a subtype of cortical neuronsEuropean Journal of Neuroscience, 2004
- Andrographolide Reduces Inflammation-Mediated Dopaminergic Neurodegeneration in Mesencephalic Neuron-Glia Cultures by Inhibiting Microglial ActivationJournal of Pharmacology and Experimental Therapeutics, 2004
- Critical role of microglial NADPH oxidase‐derived free radicals in the in vitro MPTP model of Parkinson's diseaseThe FASEB Journal, 2003
- Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic InterventionJournal of Pharmacology and Experimental Therapeutics, 2003
- ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASEAnnual Review of Neuroscience, 1999
- Co-regulation and Physical Association of the 67-kDa Monomeric Laminin Receptor and the α6β4 IntegrinJournal of Biological Chemistry, 1997
- Cell Localization and Redistribution of the 67 kD Laminin Receptor and α6βl Integrin Subunits in Response to Laminin Stimulation: An Immunogold Electron Microscopy StudyCell Adhesion and Communication, 1994
- Prognostic Significance of the 67-Kilodalton Laminin Receptor Expression in Human Breast CarcinomasJNCI Journal of the National Cancer Institute, 1993
- Signal transduction from the extracellular matrix.The Journal of cell biology, 1993
- Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitroCell, 1989